Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hamy

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Biochemical and Biophysical Research Communications|June 29, 2000
Retinoic acid switches differential expression of FGF8 isoforms in LNCaP cellsV Brondani, F Hamy
Bioorganic & Medicinal Chemistry|July 31, 1999
Molecular basis of HIV-1 TAR RNA specific recognition by an acridine tat-antagonistN Gelus, F Hamy, C Bailly
Biochemistry|January 30, 1996
Cooperativity in the binding of echinomycin to DNA fragments containing closely spaced CpG sitesC Bailly, F Hamy, M J Waring
Biochemical and Biophysical Research Communications|January 15, 1992
Comparison between synthetic nuclear localization signal peptides from the steroid/thyroid hormone receptors superfamilyF Hamy, N Helbecque, J P Henichart
Biochemical and Biophysical Research Communications|February 7, 2001
An ARE-selective DNA minor groove binder from a combinatorial approachF Hamy, G Albrecht, A Flörsheimer, et al.
Journal of Biomolecular Screening|November 2, 2001
Merged screening for human immunodeficiency virus Tat and Rev inhibitorsF Hamy, E Felder, K Lipson, et al.
Nucleic Acids Research|April 15, 1996
The binding mode of drugs to the TAR RNA of HIV-1 studied by electric linear dichroismC Bailly, P Colson, C Houssier, et al.
Biotechnology and Bioengineering|July 9, 1999
Rational optimization of a HIV-1 Tat inhibitor: rapid progress on combinatorial lead structuresT Klimkait, E R Felder, G Albrecht, et al.
Nucleic Acids Research|June 5, 1998
TAR-RNA binding by HIV-1 Tat protein is selectively inhibited by its L-enantiomerA Garbesi, F Hamy, M Maffini, et al.
Bulletin Du Cancer|September 8, 1999
[PKC 412]A Lansiaux, D Fabbro, T Meyer, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Biochemical and Biophysical Research Communications|June 29, 2000
Retinoic acid switches differential expression of FGF8 isoforms in LNCaP cellsV Brondani, F Hamy
Bioorganic & Medicinal Chemistry|July 31, 1999
Molecular basis of HIV-1 TAR RNA specific recognition by an acridine tat-antagonistN Gelus, F Hamy, C Bailly
Biochemistry|January 30, 1996
Cooperativity in the binding of echinomycin to DNA fragments containing closely spaced CpG sitesC Bailly, F Hamy, M J Waring
Biochemical and Biophysical Research Communications|January 15, 1992
Comparison between synthetic nuclear localization signal peptides from the steroid/thyroid hormone receptors superfamilyF Hamy, N Helbecque, J P Henichart
Biochemical and Biophysical Research Communications|February 7, 2001
An ARE-selective DNA minor groove binder from a combinatorial approachF Hamy, G Albrecht, A Flörsheimer, et al.
Journal of Biomolecular Screening|November 2, 2001
Merged screening for human immunodeficiency virus Tat and Rev inhibitorsF Hamy, E Felder, K Lipson, et al.
Nucleic Acids Research|April 15, 1996
The binding mode of drugs to the TAR RNA of HIV-1 studied by electric linear dichroismC Bailly, P Colson, C Houssier, et al.
Biotechnology and Bioengineering|July 9, 1999
Rational optimization of a HIV-1 Tat inhibitor: rapid progress on combinatorial lead structuresT Klimkait, E R Felder, G Albrecht, et al.
Nucleic Acids Research|June 5, 1998
TAR-RNA binding by HIV-1 Tat protein is selectively inhibited by its L-enantiomerA Garbesi, F Hamy, M Maffini, et al.
Bulletin Du Cancer|September 8, 1999
[PKC 412]A Lansiaux, D Fabbro, T Meyer, et al.
Pageof 3